Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS

This study has been completed.
Sponsor:
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00164385
First received: September 9, 2005
Last updated: October 20, 2005
Last verified: September 2005

September 9, 2005
October 20, 2005
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00164385 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS
Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS

The primary objective of Adolescent Impact is to develop and evaluate a developmentally targeted intervention designed to minimize secondary transmission risk behavior and enhance adherence to care and treatment. The intervention is delivered in 12 sessions (five one-to-one, 7 group) over a 3 month period of time. Intervention is delivered in addition to standard of care treatment at the participant's respective clinic. Participants are randomized to either an intervention or control arm; the control group receives standard of care treatment and control group participants are offered the Adolescent Impact intervention following the completion of the nine-month follow up. It is hypothesized that compared to control group participants, intervention group participants will evidence (1) improved or stable virologic and/or immunologic status, mediated by (a) adherence to prescribed antiretroviral medication and/or (b) adherence to HIV care appointments, and (2) reduction/minimization of secondary transmission risk behaviors to include (a) unprotected sex and/or needle sharing, and (b) sexual and drug use behaviors that increase risk for unprotected sex.

The primary objective of Adolescent Impact is to develop and evaluate a developmentally targeted intervention designed to minimize secondary transmission risk behavior and enhance adherence to care and treatment. The intervention is delivered in 12 sessions (five one-to-one, 7 group) over a 3 month period of time. Intervention is delivered in addition to standard of care treatment at the participant's respective clinic. Participants are randomized to either an intervention or control arm; the control group receives standard of care treatment and control group participants are offered the Adolescent Impact intervention following the completion of the nine-month follow up. It is hypothesized that compared to control group participants, intervention group participants will evidence (1) improved or stable virologic and/or immunologic status, mediated by (a) adherence to prescribed antiretroviral medication and/or (b) adherence to HIV care appointments, and (2) reduction/minimization of secondary transmission risk behaviors to include (a) unprotected sex and/or needle sharing, and (b) sexual and drug use behaviors that increase risk for unprotected sex.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
HIV Infections
Behavioral: Adolescent Impact
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  1. Confirmed HIV infection
  2. Followed at one of the participating clinics for HIV care
  3. Age 13-21 at enrollment (i.e., must be enrolled prior to 22nd birthday)
  4. Aware of HIV status and, for perinatally infected teens, the HIV status of one's biological mother
  5. Able to comprehend English well enough to participate in the study
  6. Able to understand and sign a written informed consent or assent
  7. Parental or legal guardian consent, if under the age of 18 -

Exclusion Criteria:

  1. Less than borderline intellectual functioning, as evidenced by clinician assessment or full scale IQ less than 65
  2. Acute and severe mental illness (including, but not limited to, psychosis, severe depression, or significant suicidal or homicidal ideation) -
Both
13 Years to 21 Years
Not Provided
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00164385
CDC-NCHSTP-3723, U64CCU219448, U64CCU319455, U64CCU319459
Not Provided
Not Provided
Centers for Disease Control and Prevention
Not Provided
Study Chair: Linda J Koenig, PhD Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP